AgraFlora Provides Guidance and Grow Update for its Delta Greenhouse
Picture 1 Delta, BC. AgraFlora Greenhouse VANCOUVER, British Columbia, Dec. 10, 2020 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“AgraFlora” or...
Staff
Caladrius Biosciences to Webcast Live at Life Sciences Investor Forum
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.comBASKING RIDGE,...
Quotient Limited Provides Status Update on the Initial SDS Microarray and MosaiQ Instrument for the US Market
JERSEY, Channel Islands, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today announced...
Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S.
NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical...
James S. Shannon Transitions to Chairman of the Board of Directors for MannKind
Kent Kresa, former Chairman, will continue to serve as a DirectorWESTLAKE VILLAGE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- MannKind...
SCYNEXIS Announces Advancement of Ibrexafungerp’s Intravenous Formulation to Clinical Stage and Provides Further Updates on its Clinical Studies in Patients with Life-Threatening Fungal Infections
Approval granted by health authority for the intravenous (IV) formulation of ibrexafungerp to enter Phase 1; dosing in healthy volunteers...
X4 Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for Mavorixafor for the Treatment of WHIM Syndrome
BOSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
TRACON Pharmaceuticals Announces Dosing of First Patient in ENVASARC Pivotal Trial
Company Expects Interim Data in Mid-2021SAN DIEGO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical...
Acquisition Agreement with Boehringer Ingelheim for NBE-Therapeutics Marks First Major Biotech Exit for PPF Group
€1.18 billion acquisition provides for significant returns to PPF Group as NBE’s largest shareholderSOTIO, a clinical stage immuno-oncology company, and...
Tabula Rasa HealthCare Signs Agreement with Missouri Pharmacy Association to Provide Medication Safety Technology Education to Members
Association members will have the opportunity to become Certified MedWise Advisors™ creating a State-Wide Network to support Value-Based Payer AgreementsMOORESTOWN,...
Intercept Pharmaceuticals Announces Leadership Transition
Jerry Durso Appointed CEO Effective January 1, 2021;Founder, President and CEO Mark Pruzanski to Continue as Board Member and Advisor...
Vir Biotechnology Appoints Jeffrey Hatfield to its Board of Directors
SAN FRANCISCO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jeffrey Hatfield,...
Spero Therapeutics Announces First Patient Dosed with SPR720 in Phase 2a Clinical Trial in Patients with Nontuberculous Mycobacterial Pulmonary Disease
CAMBRIDGE, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
Neoleukin Therapeutics Announces Submission of Investigational New Drug Application for NL-201 De Novo Protein Immunotherapy Candidate for Cancer
SEATTLE, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Solis Mammography Adopts iCAD’s ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment Solution
Agreement Positions Both Companies for Growth; Leading-edge AI Technology to be Installed Across Largest Independent Provider of Mammography and Breast...
BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium
- The plinabulin + pegfilgrastim combination reduces the incidence of profound neutropenia (ANC < 0.1 x 10E9 cells/L) by 53...
Acutus Medical Announces CE Mark and European Launch of AcQCross™ Transseptal System, a Fully Integrated Family of Transseptal Crossing Products
Designed to Improve Safety and Efficiency in Any Procedure Requiring Left Heart AccessCARLSBAD, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) --...
XOMA Announces Offering of Series A Cumulative Perpetual Preferred Stock
EMERYVILLE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced it has...
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company
Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15M beginning FY 2022 Aytu adds Neos’ established, multi-brand ADHD...
Establishment Labs Completes 21 Motiva Mia Patients in IRB Approved Study in Costa Rica
IRB Approval Includes Both the Ergonomix2 Diamond Implant and Mia ToolsSANTA BARBARA, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- Establishment...